tiprankstipranks
Trending News
More News >
Creightons PLC (GB:CRL)
LSE:CRL
Advertisement

Creightons (CRL) AI Stock Analysis

Compare
3 Followers

Top Page

GB:CRL

Creightons

(LSE:CRL)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
32.00p
▲(1.59% Upside)
Creightons' strong financial performance and attractive valuation are the primary drivers of its overall score. The robust balance sheet and low P/E ratio suggest financial stability and potential undervaluation. However, technical indicators show a bearish trend, and the decline in free cash flow growth is a risk that needs addressing.
Positive Factors
Strong Balance Sheet
A low debt-to-equity ratio indicates financial stability, providing Creightons with the flexibility to invest in growth opportunities and withstand economic downturns.
Improving Profitability Margins
Improved gross profit margins suggest effective cost control, enhancing the company's ability to generate higher profits from its sales, which is crucial for long-term sustainability.
Revenue Growth
Consistent revenue growth reflects Creightons' ability to expand its market presence and adapt to consumer demands, supporting long-term business expansion.
Negative Factors
Decline in Free Cash Flow
A substantial decline in free cash flow growth can limit Creightons' ability to fund new projects, pay down debt, or return capital to shareholders, impacting future financial flexibility.
Low Net Profit Margin
A low net profit margin indicates that Creightons may not be converting enough of its revenue into profit, which could hinder its ability to reinvest in the business or weather economic challenges.
Free Cash Flow to Net Income Ratio
While the ratio indicates decent cash generation, the decline in free cash flow growth suggests potential challenges in sustaining cash flow levels, which could affect future investments and financial health.

Creightons (CRL) vs. iShares MSCI United Kingdom ETF (EWC)

Creightons Business Overview & Revenue Model

Company DescriptionCreightons (CRL) is a UK-based company specializing in the formulation and manufacture of personal care products, including skincare, haircare, and body care items. The company operates in the beauty and personal care sector, providing a range of private label and branded products to retailers and consumers, both domestically and internationally. Creightons is known for its innovative product development and commitment to quality, catering to various market segments with its diverse portfolio.
How the Company Makes MoneyCreightons generates revenue through multiple streams, primarily by manufacturing private label products for major retailers, which account for a significant portion of its sales. Additionally, the company sells its own branded products directly to consumers and through third-party retailers. Key revenue streams include contracts with large retail chains, sales from its own brand lines, and international exports. Strategic partnerships with retailers enhance distribution and visibility, while the company's focus on product innovation and trend responsiveness helps maintain competitive pricing and customer interest, further driving sales.

Creightons Financial Statement Overview

Summary
Creightons shows strong financial performance with improving revenue and profitability margins. The balance sheet is robust with low leverage, enhancing financial stability. However, the significant decline in free cash flow growth is a concern and needs attention.
Income Statement
75
Positive
Creightons has shown a positive revenue growth rate of 2.56% in the latest year, recovering from a decline in previous years. The gross profit margin has improved to 44.67%, indicating efficient cost management. However, the net profit margin is relatively low at 4.54%, suggesting room for improvement in profitability. The EBIT and EBITDA margins have also improved, reflecting better operational efficiency.
Balance Sheet
80
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.13, indicating low leverage and financial stability. The return on equity is 10.12%, showing effective use of equity to generate profits. The equity ratio is healthy, suggesting a solid capital structure with a good proportion of equity financing.
Cash Flow
65
Positive
Creightons experienced a significant decline in free cash flow growth, down by 59.86%, which is a concern. However, the operating cash flow to net income ratio is 0.31, indicating that the company generates sufficient cash from operations relative to its net income. The free cash flow to net income ratio is 0.77, showing decent cash generation relative to profits.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue54.07M54.07M53.19M58.57M61.16M61.60M
Gross Profit23.97M24.15M22.83M24.05M25.75M24.48M
EBITDA5.24M5.24M-1.21M2.69M5.34M6.94M
Net Income2.45M2.45M-3.53M514.00K3.11M4.33M
Balance Sheet
Total Assets38.14M38.14M36.14M45.54M47.85M33.55M
Cash, Cash Equivalents and Short-Term Investments3.66M3.66M3.14M1.65M840.00K6.56M
Total Debt3.25M3.25M3.92M7.28M8.22M3.96M
Total Liabilities13.91M13.91M14.09M20.06M22.17M13.46M
Stockholders Equity24.22M24.22M22.05M25.48M25.68M20.09M
Cash Flow
Free Cash Flow2.39M2.23M5.42M4.67M-508.00K4.17M
Operating Cash Flow2.82M2.91M6.03M5.81M1.22M5.41M
Investing Cash Flow-662.00K-662.00K-608.00K-2.64M-8.09M-1.07M
Financing Cash Flow-1.65M-1.73M-3.95M-2.35M1.16M-1.46M

Creightons Technical Analysis

Technical Analysis Sentiment
Positive
Last Price31.50
Price Trends
50DMA
28.99
Positive
100DMA
31.59
Negative
200DMA
32.81
Negative
Market Momentum
MACD
0.55
Negative
RSI
64.84
Neutral
STOCH
88.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRL, the sentiment is Positive. The current price of 31.5 is above the 20-day moving average (MA) of 29.03, above the 50-day MA of 28.99, and below the 200-day MA of 32.81, indicating a neutral trend. The MACD of 0.55 indicates Negative momentum. The RSI at 64.84 is Neutral, neither overbought nor oversold. The STOCH value of 88.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CRL.

Creightons Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
£181.77M11.3525.14%5.69%6.38%-10.55%
72
Outperform
£25.40M21.035.67%0.03%-5.67%
72
Outperform
£20.56M8.389.67%3.02%2.83%
68
Neutral
£198.64M5.8242.11%2.41%-0.89%1.30%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
52
Neutral
£286.09M-49.42-2.51%4.47%-2.67%89.86%
39
Underperform
£24.05M-0.51-31.02%-4458.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CRL
Creightons
31.50
-4.01
-11.29%
GB:MCB
McBride
121.60
15.37
14.47%
GB:PZC
PZ Cussons
77.30
-1.05
-1.34%
GB:W7L
Warpaint London
206.00
-300.46
-59.33%
GB:VINO
Virgin Wines UK PLC
49.50
15.00
43.48%
GB:REVB
Revolution Beauty Group plc
2.94
-9.83
-76.98%

Creightons Corporate Events

Business Operations and StrategyFinancial Disclosures
Creightons PLC Reports Interim Results with Strategic Focus on Growth and Efficiency
Neutral
Nov 19, 2025

Creightons PLC reported its unaudited interim results for the first half of 2025, showing a slight increase in revenue but a decrease in overall profitability due to higher labor costs and customer-related disruptions. The company has made significant operational improvements, including warehouse and digital upgrades, and remains focused on private label growth, international expansion, and operational efficiency. Despite challenges, Creightons is optimistic about future growth, driven by strategic investments and a focus on market agility.

The most recent analyst rating on (GB:CRL) stock is a Buy with a £32.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.

Delistings and Listing ChangesRegulatory Filings and Compliance
Creightons Updates on Employee Share Option Scheme and Voting Rights
Neutral
Sep 15, 2025

Creightons has announced its six-monthly block listing return related to its Employee Share Option Scheme. During the period from March 12 to September 12, 2025, the company issued 91,940 securities, leaving a balance of 5,138,520 unallotted securities. Additionally, the total number of ordinary shares with voting rights now stands at 68,527,323, reflecting a slight decrease due to a previous miscalculation. This update is crucial for shareholders to accurately assess their holdings and comply with regulatory requirements.

The most recent analyst rating on (GB:CRL) stock is a Hold with a £33.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.

Regulatory Filings and Compliance
Creightons Announces Total Voting Rights Update
Neutral
Aug 29, 2025

Creightons plc has announced the total number of its ordinary shares in issue, which stands at 70,133,123, with 1,600,000 held in treasury. This results in 68,533,123 shares having voting rights. This information is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:CRL) stock is a Buy with a £40.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.

Executive/Board ChangesStock BuybackShareholder Meetings
Creightons plc Successfully Passes All AGM Resolutions
Neutral
Aug 28, 2025

Creightons plc announced that all resolutions presented at its Annual General Meeting were approved by shareholders. The resolutions included the re-election and appointment of directors, approval of the Directors’ Remuneration Report, and authorization for equity securities allotment and share buyback. The board is committed to engaging with major shareholders to understand their views on certain resolutions related to securities allotment and share buyback.

The most recent analyst rating on (GB:CRL) stock is a Buy with a £40.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 25, 2025